MIAMI, FL – February 16, 2021 – Progressive Care Inc. (OTCQB:RXMD) (“Progressive Care” or the “Company”), a personalized healthcare services and technology company, is excited to announce a new partnership with EagleForce Health, LLC to integrate its proprietary telehealth platform (“myVax™”) and develop a platform for the Company’s Digital Passport for COVID-19 Testing and Vaccination results.
“The need for a digital passport to help manage our coming post-pandemic environment is paramount, and we believe myVax™ can develop into a market-leading solution to meet that need,” remarked Alan Jay Weisberg, CEO and Chairman of Progressive Care. “This partnership will allow Progressive Care to expand our telehealth presence and scale more of our operations in a geographically agnostic manner through significant exposure to one of the most important opportunities defining the intermediate-term future in the business economy: digital proof of vaccination.”
The myVax™ platform is expected to launch over the coming weeks and to include complete patient scheduling, telehealth, and tele-pharmacy platform services. “Our partnership with Progressive Care is designed to focus on the COVID-19 digital passport roll-out to support the Company’s first line health service providers who see, touch and bring solutions directly to the patient. Phase 1 of the myVax™ platform launch will be made available to patient population well beyond the COVID 19 pandemic. The full scope of our commitment to this partnership will bring transformational outcomes to patient adherence and self-management of disease to the rapidly growing Telehealth marketplace. We are so proud to have Progressive Care as a partner.” said Stanley Campbell, CEO and Chairman of EagleForce Health, LLC.
The platform will manage an individual’s COVID-19 Vaccine and Test Journey documenting all transitions, including healthcare appointments, billing, and telehealth services. This will also include a Digital Passport or Digital Wallet that is QR-coded for registration, verification, and documentation of COVID-19 vaccination and/or test results.
This is expected to provide a powerful tool for various processes that the Company believes will come to depend upon accurate real-time virus spread risk abatement, including merchants such as cruise lines, airlines, sports venues, high-population-density, manufacturing, packing, or shipping facilities, and institutions such as school districts, universities, court proceedings, public transportation systems, and other service providers.
Mr. Weisberg added, “The COVID-19 digital passport roll-out will be our Phase 1 service launch for the myVax™ platform; however, the full scope of this partnership expands well beyond COVID-19 and is expected to powerfully augment our overall positioning in the rapidly growing
Telehealth marketplace. We look forward to providing further updates and additional detail in subsequent communications.”
For more information about Progressive Care, please visit the company’s website. Connect and stay in touch with us on social media:
Progressive Care Inc. https://www.facebook.com/ProgressiveCareUS/ https://twitter.com/ProgressCareUS
PharmCoRx
https://www.pharmcorx.com/get-tested-now https://www.facebook.com/pharmcorx/ https://twitter.com/PharmCoRx
ClearMetrX https://www.clearmetrx.com/ https://www.facebook.com/clearmetrx/
About Progressive Care: Progressive Care Inc. (OTCQB: RXMD), through its subsidiaries, is a Florida health services organization and provider of prescription pharmaceuticals, compounded medications, provider of tele-pharmacy services, the sale of anti-retroviral medications, medication therapy management (MTM), the supply of prescription medications to long-term care facilities, and health practice risk management.
About MyVax
MyVax™ National Immunization Management system is deployed and scaled to serve as a single national platform for the emergency authorization of the COVID-19 vaccines, the associated lab reports as well as the daily routine management of other vaccines and medications for chronic conditions. The national infrastructure operates at every point-of-sale pharmacy with real-time alerting functionality that reaches across state borders to assure the safety and efficacy of all patients while enabling self-monitoring and management of chronic conditions and medications. This platform is designed to promote adherence and self-management of disease including routine immunizations and preventive care with access to care team through HIPAA compliant Telehealth platform. MyVax™ is designed to provide every man, woman, and child access to their own COVID-19 Vaccination Information and Medical Information for 25 years. MyVax™ allows the patient to own their own data and receive real-time scheduling and alerts directly from any provider, pharmacy, or payer from anyplace in the nation.
About EagleForce:
EagleForce pedigree was established within the commercial and government health sectors and is recognized as a leading technology solution’s company providing a broad range of eligibility systems development, organizational and operational assistance to “Big Data Analytics” processing, interoperability, predictive analytics, and other IT functions. The Companies evidence-based eligibility & real-time monitoring systems have been deployed to solve some of the biggest technology challenges in the world. Today, the EagleForce solutions have been adopted by many leading healthcare companies including pharmaceutical manufacturers, PBMs, chain pharmacies and drug wholesalers. EagleForce Health delivers the most advanced evidence-based clinical insights and business intelligence for accurate and persistent information available today. Leveraging the secure technology that has provided knowledge and analytics to both the commercial and government industries for many years, EagleForce Health brings this high pedigree of advanced analytics, information sharing, security, and privacy to healthcare.
Cautionary Disclosure Regarding Forward-Looking Statements Forward-Looking Statements contained herein that are not based upon current or historical fact are forward-looking in nature and constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such forward-looking statements reflect the Company’s expectations about its future operating results, performance, and opportunities that involve substantial risks and uncertainties. When used herein, the words “anticipate,” “believe,” “estimate,” “upcoming,” “plan,” “target,” “intend” and “expect” and similar expressions, as they relate to Progressive Care Inc., its subsidiaries, or its management, are intended to identify such forward-looking statements. These forward-looking statements are based on information currently available to the Company and are subject to a number of risks, uncertainties, and other factors that could cause the Company’s actual results, performance, prospects, and opportunities to differ materially from those expressed in, or implied by, these forward-looking statements.
Public Relations Contact: Carlos Rangel carlosr@pharmcorx.com
Copyright 2022 © Progressive care inc.
Forward-looking Statements – This website contains forward-looking statements about our business. These forward-looking statements do not relate strictly to historical or current facts. Forward-looking statements involve risks and uncertainties and include statements regarding, among other things, our projected revenue growth and profitability, our growth strategies and opportunity, anticipated trends in our market and our anticipated needs for working capital. Forward-looking statements are generally identifiable by the use of words like “may,” “will,” “should,” “anticipate,” “estimate,” “plans,” “potential,” “projects,” “continuing,” “ongoing,” “expects,” “management believes,” “we believe,” “we intend” or the negative of these words or other variations on these words or comparable terminology. You should not put undue reliance on these forward-looking statements. Forward-looking statements are subject to known and unknown risks, uncertainties and other factors that may cause actual results to differ materially from those reflected in such statements including: risks associated with current and potential future healthcare reforms; risks relating to technology failures or breaches; aspects of our business which are outside, risks relating to management and key personnel changes including attracting and retaining key personnel; failure to comply with legal and regulatory requirements; risks relating to access to capital and credit markets; risks related to indebtedness; exposure to claims and liabilities; changes in industry pricing benchmarks; and other risks and uncertainties that are described in the Risk Factors section of our recently filed Form 10-12G, including the presentation of financial statements and notes thereto, and other reports we have filed with the U.S. Securities and Exchange Commission. These reports are available at www.sec.gov or by calling our Investor Relations department at (888) 919-7411 ext. 221. Forward-looking statements speak only as of the date they are posted to this website, unless an earlier date is indicated, and we do not undertake any obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.
Non-GAAP FinancialMeasures–This presentationincludes certain “non-GAAP financial measures” as defined in Regulation G under the Securities Exchange Act of 1934. Schedules are attached that reconcile the non-GAAP financial measures included in this presentation to the most directly comparable financial measures calculatedand presentedin accordancewith Generally Accepted Accounting Principles in the United States. You should carefully read Progressive Care’s periodic and currentfilings on the OTCQB website for definitions and further explanation and disclosure regarding our use of non-GAAP financial measures and such filings should be read in conjunction with this presentation.
Type your name and email and we'll send you RXMD's investor's presentation in the next few minutes!
.png){kind=logo}
